Literature DB >> 8431695

Liver lesion detection: comparison between excitation-spoiling fat suppression and regular spin-echo at 1.5T.

R C Semelka1, H Hricak, K G Bis, W C Werthmuller, C B Higgins.   

Abstract

The role of excitation-spoiling fat suppression (fatsat) imaging in the detection of liver lesions was assessed comparing short TR/TE and lont TR/TE spin-echo (SE) sequences with and without excitation-spoiling fat suppression in 25 patients at 1.5T. The study included patients with liver metastases (n = 21), primary liver cancer (n = 3), and hepatic adenoma (n = 1). Liver lesion detection and lesion-liver signal-to-noise ratios (SNR) were determined for the various imaging sequences in a prospective fashion. Liver lesion-liver SNR were highest for long TR/TE (2000-2500/70-80) fatsat images (12.7 +/- 4.8) compared to long TR/TE regular SE (2000-2500/70-80) images (8.8 +/- 5.6) [(p = ns) (not significant)], short TR/TE (200-400/15-20) fatsat images (-6.2 +/- 4.8) (p = 0.05), and short TR/TE regular SE images (-4.9 +/- 3.2) (p < 0.01). Lesion detection was greatest for long TR/TE fatsat (86) followed by long TR/TE regular SE (78) (p = 0.05), short TR/TE fatsat (65) (p < 0.01), and short TR/TE regular SE (60) (p < 0.01). The results of this study suggest that excitation-spoiling fat suppression may improve liver lesion detection and conspicuity.

Entities:  

Mesh:

Year:  1993        PMID: 8431695     DOI: 10.1007/bf00201703

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  18 in total

1.  Liver metastases: optimization of MR imaging pulse sequences at 1.0 T.

Authors:  M R Paling; P L Abbitt; J P Mugler; J R Brookeman
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

2.  Variable flip angle imaging and fat suppression in combined gradient and spin-echo (GREASE) techniques.

Authors:  S Vinitski; D G Mitchell; J Szumowski; D L Burk; M D Rifkin
Journal:  Magn Reson Imaging       Date:  1990       Impact factor: 2.546

3.  MR imaging of the optic nerve and sheath: correcting the chemical shift misregistration effect.

Authors:  D L Daniels; J B Kneeland; A Shimakawa; K W Pojunas; J F Schenck; H Hart; T Foster; A L Williams; V M Haughton
Journal:  AJNR Am J Neuroradiol       Date:  1986 Mar-Apr       Impact factor: 3.825

4.  Comparison of STIR and spin-echo MR imaging at 1.5 T in 90 lesions of the chest, liver, and pelvis.

Authors:  W P Shuman; R L Baron; M J Peters; P K Tazioli
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

5.  Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT.

Authors:  D D Stark; J Wittenberg; R J Butch; J T Ferrucci
Journal:  Radiology       Date:  1987-11       Impact factor: 11.105

6.  Detection of hepatic metastases: analysis of pulse sequence performance in MR imaging.

Authors:  D D Stark; J Wittenberg; R R Edelman; M S Middleton; S Saini; R J Butch; T J Brady; J T Ferrucci
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

7.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.

Authors:  J P Heiken; P J Weyman; J K Lee; D M Balfe; D Picus; E M Brunt; M W Flye
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

8.  Short TI inversion-recovery imaging of the liver: pulse-sequence optimization and comparison with spin-echo imaging.

Authors:  M Dousset; R Weissleder; R E Hendrick; D D Stark; C J Fretz; G Elizondo; P F Hahn; S Saini; J T Ferrucci
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

9.  Detection of hepatic metastases with MR imaging: spin-echo vs phase-contrast pulse sequences at 0.6 T.

Authors:  E Rummeny; S Saini; D D Stark; R Weissleder; C C Compton; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1989-12       Impact factor: 3.959

10.  Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.

Authors:  R C Semelka; H Hricak; S K Stevens; R Finegold; E Tomei; P R Carroll
Journal:  Radiology       Date:  1991-03       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.